Nov 26, 09:07
50% of moneycontrol users recommend buying Venus Remedies.
What's your call on Venus Remedies today?
Read 9 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3535.00||-0.89||3581.70||2250.00||60,224.32|
|Sep' 14||Jun' 14||Mar' 14||Dec' 13|
|No Mutual Funds Holding the share|
DCB Bank Recommended on Aug 19th 2014
Recommended price 81.00 | Peak from reco 107.05 31.51%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Venus Remedies is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 256.47 crore.The company has reported a standalone sales of Rs 125.38 crore and a Net Profit of Rs 10.30 crore for the quarter ended Sep 2014.
The company management includes Pawan Chaudhary - Chairman & Managing Director, Manu Chaudhary - Joint Managing Director, Peeyush Jain - Deputy Managing Director, Ashutosh Jain - Executive Director, Gilbert Wenzel - Non Executive Director, S K Chadha - Non Executive Director, Jagdish Chander - Non Executive Director, Hari Pal Verma - Non Executive Director, Soumitra Sengupta - Non Executive Director.
It is listed on the BSE with a BSE Code of 526953 and the NSE with an NSE Code of VENUSREM.
Its Registered office is at S.C.O. 857, C. No. 10, IInd Floor,,NAC Manimajra Chandigarh,Chandigarh - 160101.
Their Registrars are Link Intime India Pvt. Ltd.